Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Utah Medical Products Q3 2026 Results: Net Income $2.79M, Up 5.9% YoY

For the nine months ended September 30, 2026, Utah Medical Products reported net sales of $25.87 million, a decrease from $29.48 million in the prior year period. Despite the decline in revenue, the company maintained profitability with a net income of $8.08 million and ended the period with a strong cash and investment balance of $85.20 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue8.69.8
Gross profit4.85.6
Profit before tax3.43.3
Net income2.82.6
EPS (diluted, $ a share)$0.88$0.82

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+5.9%
Revenue, year on year-12.1%
Gross margin56.1%
Operating margin32.4%
Source

10-Q filed with the SEC, NASDAQ: UTMD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Utah Medical Products Inc: key numbers

Share price
$72.36Close, Nov 16
Market cap
$206M
Shares outstanding
2.85MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Utah Medical Products Inc

All →
12:59 PM ET 8-K
Dividend

Utah Medical Products Dividend

Utah Medical Products, Inc. (UTMD) announced that its Board of Directors has approved a 1.6% increase to its regular quarterly cash dividend. The new dividend of $0.315 per share is payable on January 5, 2027, to shareholders of record as of December 17, 2026.

4:46 PM ET Form 4
Insider Buying

Utah Medical Products Chairman, CEO Kevin L. Cornwell Buys $66.8K of Stock

Kevin L. Cornwell, Chairman, CEO, bought 1,000 shares of Utah Medical Products Inc at $66.75 a share, worth $66.8K in total on Oct 29, 2026. Shares held after the trade: 189,472 (+0.5%).

Value
$66.8K
Shares
1,000
Price
$66.75
Role
Chairman, CEO
Holding change
+0.5%
Trade date
Oct 29, 2026
3:11 PM ET 8-K
Financial Results

Utah Medical Products Financial Results

Utah Medical Products reported its 3Q 2026 financial results, showing a 12.1% decrease in consolidated revenues to $8.6 million compared to the prior year. Despite the revenue decline caused by the loss of two major customers, the company achieved a 6% increase in net income for the quarter, supported by the acquisition of Orion Medical Supplies Ltd in August 2026.

Term
3Q 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.